Thomson Pharma: The Cure for Pharmaceutical Research

By Felter, Laura M. | Searcher, October 2005 | Go to article overview

Thomson Pharma: The Cure for Pharmaceutical Research


Felter, Laura M., Searcher


Providing business, patent, and R&D information on pipeline drugs in an end-user preferred format to a multispecialist team poses a challenge. And that doesn't include the efforts required for setting up alerts based on drug, therapeutic area, or companies of interest. For both mainline pharmaceutical companies and those only peripherally involved in the field, it can become a particularly interesting balancing act, one that requires meeting data demands in the most cost-effective and time-efficient ways possible with available subscriptions, while supporting collaboration of business teams in juggling request priorities and overlapping content. The task demands investigating access--especially customized access--to critical end-user tools.

With this challenge in mind, I took a tour of the Thomson Pharma product with the help of Rachel Buckley, director of product development within the pharma/chemistry markets of Thomson Scientific.

Thomson Scientific, which operates information resources such as Delphion, Derwent World Patents Index, and IDdb (Investigational Drugs database), provides a single interface product that unifies its different offerings. Thomson Pharma content not only pulls from these Thomson Scientific sources, but also from Thomson Healthcare, Thomson Dialog, Thomson Financial, and Thomson Legal and Regulatory. The end result is a highly functional, easy-to-use product for the end user and information professional alike, with a single entry to the most comprehensive amassing of content in the pharmaceutical industry.

This Web-based tool serves both end users and information professionals working in pharmaceutical research. It encompasses content for the business, intellectual property, legal and regulatory, and R&D needs of drug discovery and development. It draws from the best Thomson interfaces, improved upon by the key team members of each Thomson product. How successful the search interface will be for the information professional remains to be seen with the yet-to-be-launched "expert search." However, there is plenty of functionality already available for both user types, enough to not only help them keep abreast of developments in the field, but to derive search results for product teams known for the diversity of their specialized backgrounds and information requirements.

Ultimately, the advantage and benefit of Thomson Pharma lies in providing users with the ability to view and search the latest information specific to their interests from their desktops with content based on a selection of specialty (biology, chemistry, clinical research, licensing and business, competitive intelligence) or general-interest topics that the user can further refine by 12 therapeutic areas. With the ability to mix and match the information provided via "portlets," one starts to see the flexibility and personalization available to users of this product.

Interface

According to Buckley, who headed up the Thomson Pharma product development team in 2003, the largest challenge the team faced was coming up with an integrated solution incorporating the best features of the individual Thomson Web sites while retaining simplicity in design--all this despite the complexity of the content. The result is an interface greater than the sum of its parts. "We had many Web-based features to choose from, but not necessarily at the level of flexibility required. What differentiates Thomson Pharma is the breadth of content, flexibility, and intuitiveness it presents in a corporate environment."

The opening screen of Thomson Pharma (see Figure 1 above) offers a default display of content defined as "general interest" covering "all therapy areas." The user may then launch into browsing any of the specialty and therapeutic area combinations, viewing predefined portlets of relevant information. The personalization (and fun) factor comes from the flexibility to create multiple home pages in which you not only select a specialty and therapeutic area, but get to choose the type of information displayed.

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Thomson Pharma: The Cure for Pharmaceutical Research
Settings

Settings

Typeface
Text size Smaller Larger
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.